ICHG 2019 Speakers
Dr Rebecca Painter
Gynaecologist and fellow in fetal maternal medicine
University of Amsterdam
Dr Painter is a gynaecologist and fellow in fetal maternal medicine at the University of Amsterdam, Academic Medical Centre. Her clinical interests focus on nutrition in pregnancy, and include maternal obesity, diabetes in pregnany and hyperemesis gravidarum.
In her PhD, she established that long term effects of maternal undernutrition during the Dutch Famine of 1944-45. Her current research interests include the long term health of children conceived by IVF and of those conceived by obese women. Her group recently conducted the first randomised controlled trial to study the utility of tube feeding in hyperemesis gravidarum.
Chair of Trustees, PhD Student
Pregnancy Sickness Support, Plymouth University
A three time hyperemesis gravidarum survivor, Caitlin Dean dedicates her time and energy in to raising awareness about the condition in the media, providing support to sufferers and writing prolifically on the subject through her Spewing Mummy blog, healthcare journals and magazines. As a Registered General Nurse and Chairperson for UK charity Pregnancy Sickness Support she is involved in research, pioneering services and health care professional education about HG. She has authored two books on the condition: Hyperemesis Gravidarum – The Definitive Guide for women, partners and healthcare professionals; and How to be an HG Hero for the children of women suffering.
Following her MSc in Clinical Research in 2016 in which she surveyed women's experiences of treatment for HG in the UK, Caitlin is currently undertaking a PhD to further the HG research agenda. Her particular interest is in the benefits of pre-pregnancy planning for subsequent HG pregnancies and prophylactic treatment.
Professor of Research
UCLA, USC and HER Foundation
Marlena Schoenberg Fejzo, Ph.D., is an American medical scientist and professor of research on Hyperemesis Gravidarum (HG) and gynecologic cancer. She received her Ph.D. from Harvard University in 1995 and currently has joint appointments at the University of California, Los Angeles and the University of Southern California. She has published peer-reviewed scientific articles on many diseases of women including ovarian cancer, breast cancer, multiple sclerosis, and discovered the first gene for uterine fibroids. She provided evidence for a genetic component to HG, is an advisor for the Hyperemesis Education and Research Foundation, and runs a study to identify genes and epidemiologic factors linked to HG.
Registrar in obstetrics and gynaecology and PhD student
University of Amsterdam
Dr Grooten is a registrar in obstetrics and gynaecology at the University of Amsterdam, Academic Medical Centre. She is conducting her PhD on hyperemesis gravidarum (HG), covering aetiologic markers, treatment options and offspring cardiometabolic consequences. She has just completed a nationwide randomised controlled trial investigating the effectiveness of early nasogastric tube feeding in HG (MOTHER trial) and is currently developing a large Delphi survey including multiple stakeholders to develop international consensus on HG definition and core outcomes for HG research (DCOHG project).
Laila is an epidemiologist whose main interests are in pregnancy and the perinatal period, and the relationships between maternal and child health. She is an Associate Professor at the University of Nottingham where she conducts large studies on adverse drug effects and consequences of illness mainly using routinely collected health data linked across multiple sources to create large population-based study cohorts.
Her current research in hyperemesis gravidarum (HG) uses information from women’s interactions with their general practitioner and hospital to describe the national burden of HG and severe NVP, what makes some women at greater risk than others, whether early treatment from general practice may result in fewer hospital admissions, and the safety of using antiemetic medications in pregnancy. Laila welcomes further collaborations locally and internationally. More information about Laila’s work and publications can be found at https://www.nottingham.ac.uk/medicine/people/laila.tata
Professor Steve Robson
Professor of Fetal Medicine
Institute of Cellular Medicine
Stephen Robson MB BS MRCOG MD FRCP(Edin) is Professor of Fetal Medicine and a member of the Institute of Cellular Medicine at Newcastle University. He is Clinical Director of the NIHR Clinical Research Network in the North East and North Cumbria. His main research interests are: uterine cell signalling, mechanisms of myometrial quiescence and clinical trials in the area of high risk pregnancy and prenatal screening
Senior Research Fellow in eHealth
Dr Fiaschi is a Senior Research Fellow in eHealth at Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, UK and her research is focussed on perinatal epidemiology, including pregnancy complications, adverse pregnancy outcomes and drugs safety in pregnancy. She received her B.Sc., M.Sc. in Electronic Engineering with Biomedical Specialization from the University of Pisa, Italy, and her PhD in Computer Science (Bioinformatics) from the University of Nottingham, UK, on the analysis of Single Nucleotide Polymorphisms in disease association studies. Her expertise includes large databases management, pregnancy longitudinal data analysis, medical data mining and programming. In the most recent project, she carried out an assessment of risk factors, adverse maternal and birth outcomes and management of nausea and vomiting in pregnancy and hyperemesis gravidarum, making use of some of the largest primary and secondary care electronic datasets in the UK.
Kimber Wakefield MacGibbon
Kimber Wakefield MacGibbon, Registered Nurse, is the co-founder and Director of the Hyperemesis Education and Research Foundation. In collaboration with the University of Southern California and the University of California Los Angeles, she has coauthored over two dozen papers on HG that study the short and long-term maternal and fetal impact of HG, as well as explore a genetic causation. She has spoken in Washington, DC at a congressional briefing on HG and authored numerous educational materials. She oversees the daily operations of the foundation and regularly assists clinicians, families and researchers to minimise the suffering and loss associated with HG.